Calorie-Restricted Diet Shows Promise in Improving Symptoms of Crohn's Disease
Diet is a common concern for people with Crohn’s disease, and this randomized trial suggests a structured, short-term calorie-restricted diet may reduce symptoms and markers of gut inflammation. Evidence-based dietary approaches could eventually offer non-drug options or complements to existing treatments.
Adults with Crohn’s disease (especially mild-to-moderate cases), caregivers, clinicians advising on diet and IBD management, and researchers studying diet–microbiome–inflammation links.
What To Know
Short-term calorie restriction using a fasting-mimicking diet (FMD) was reported in a randomized trial to improve symptoms and reduce inflammatory markers in people with mild-to-moderate Crohn's disease. The reported intervention involved 5-day-per-month, plant-based, low-calorie (≈700–1,100 kcal/day) meal periods over three months.
Improvements included patient-reported symptom benefits and decreases in fecal calprotectin and some inflammatory measures; some participants had mild side effects like fatigue or headache. The study was conducted across multiple U.S.
centers and funded by several organizations; one listed author has financial ties to the supplier of the FMD meals and holds related patents. Researchers note the need for further work to confirm mechanisms (including microbiome changes) and to guide clinical recommendations.
If you read the original Nature Medicine paper, check study size, eligibility criteria, exact outcomes, and disclosures to understand how this trial might (or might not) apply to you. This article summarizes the trial results but does not provide clinical guidance.
Results come from a randomized trial reported in Nature Medicine but involve a relatively short intervention (monthly 5-day FMD cycles for three months) and about 97 participants. One author has equity interest related to the diet supplier, which is disclosed in the article. Larger and longer studies are needed before changing medical care.